Financial hardship drives unhappiness in people living with dementia, study finds
By
Kristen Fischer
Jan 05, 2024
A new study in the Journal of the American Geriatrics Society reveals just how tough it can be financially to live with dementia.
Biogen is dropping controversial Alzheimer’s drug Aduhelm
Jan 31, 2024
Biogen said it will shift its focus to a newer Alzheimer’s drug, Leqembi, which it markets in a partnership with Japan-based Eisai. Leqembi received FDA approval last year.
Where dementia is most prevalent
By
Lois A. Bowers
Feb 03, 2016
A new tool from the federal government provides county- and state-level prevalence data for Alzheimer’s/dementia and 15 other chronic conditions.
New framework for national plan on aging aims to ease access to LTSS for older adults
By
Kimberly Bonvissuto
May 31, 2024
Creating a more person-centered, accessible system of care to enable older adults to more easily connect with long-term services and supports is part of a strategic framework for a national plan on aging...
More news for Tuesday, Feb. 7
Feb 06, 2017
Search for Alzheimer’s drugs is more urgent than ever … How would Republican plans for Medicaid block grants actually work? … Long-term care advocates call on Canadian government to invest...
Medicare mulls coverage for controversial drug for Alzheimer’s disease
Jul 13, 2021
CMS says a final decision on coverage is not likely until next spring.
More news for Tuesday, Aug. 31
Aug 31, 2021
Groups request extension for vaccine mandate in Maine … Senior housing providers can take action to protect older adults from the end of eviction moratorium … Multiple defendants indicted in ‘grandparent...
Medicare will cover new class of Alzheimer’s drugs if fully approved by FDA, with limits
Jun 02, 2023
Drug makers also will have to gather and keep data in a registry showing how the drugs are working in the real world.
Medicare monthly premiums to drop for seniors
Sep 28, 2022
The fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10%.
Natural environments may cut hospitalization for patients with neurodegenerative diseases
Dec 30, 2022
The normalized difference vegetation index was negatively associated with hospitalization for Alzheimer’s disease and related dementia as well as Parkinson’s disease.